FAKTOR OPTIONSSCHEIN - QUEST DIAGNOSTICS | Real-time BOERSE MUENCHEN 03:09:21 2024-06-28 EDT | ||
| 2.24 EUR | +6.67% |
|
| Current month | +13.51% | ||
| 1 month | +15.38% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
More news
| Date | Price | Change |
|---|---|---|
| 24-06-28 | 2.24 | +6.67% |
| 24-06-27 | 2.1 | -1.41% |
| 24-06-26 | 2.13 | +3.40% |
| 24-06-25 | 2.06 | +7.85% |
| 24-06-24 | 1.91 | -5.45% |
Real-time BOERSE MUENCHEN
Last update June 28, 2024 at 03:09 am
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | Goldman Sachs |
| WKN | GG20AV |
| ISIN | DE000GG20AV3 |
| Date issued | 2024-01-22 |
| Strike | 151.1 $ |
| Maturity | Unlimited |
| Parity | 6.03 : 1 |
| Emission price | 8.42 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 16.58 € |
|---|---|
| Lowest since issue | 1.43 € |
| Spread | 0.1 € |
| Spread % | 4.27% |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
137.3
USD
Average target price
147
USD
Spread / Average Target
+7.03%
- Stock Market
- Certificates
- Certificat
